See every side of every news story
Get Started
SubscribeLogin
Israel-Hamas Conflict
Volodymyr Zelenskyy
Ukraine War
Donald Trump
Republican Party
Democratic Party
US Politics
White House
Ramadan
Oval Office
JD Vance
Social Media
The Oscars
Published • loading... • Updated

WuXi Biologics Again Passed GMP Inspection by Japan PMDA

  • WuXi Biologics has again passed the GMP inspection by Japan's Pharmaceuticals and Medical Devices Agency for its drug substance facilities in Wuxi city.
  • The inspection covered the quality processes and the entire production system, concluding without issues.
  • WuXi Biologics has successfully passed 42 regulatory inspections and received 97 license approvals globally.
  • Dr. Chris Chen emphasized that the company's quality system supports sustainable growth and enables global partners to deliver life-saving treatments.
Insights by Ground AI
Does this summary seem wrong?

31 Articles

All
Left
2
Center
7
Right
3
The Berkshire EagleThe Berkshire Eagle
+30 Reposted by 30 other sources

WuXi Biologics Again Passed GMP Inspection by Japan PMDA

WUXI, China, Feb. 26, 2025 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), today announced that it has again passed the GMP inspection by Japan's Pharmaceuticals and Medical Devices Agency (PMDA)…

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 58% of the sources are Center
58% Center
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

The Sentinel broke the news in Carlisle, United States on Thursday, February 27, 2025.
Sources are mostly out of (0)

Similar News Topics

Pharma

Pharma

Wuxi

Wuxi

You have read out of your 5 free daily articles.

Join us as a member to unlock exclusive access to diverse content.

News
For You
Search
BlindspotLocal